TGFB1 and atrial fibrillation: TGF‐β1 gene is recognized as a central regulator of fibroblast activation in AF pathogenesis, with its inhibition demonstrating therapeutic potential for ameliorating atrial fibrosis and AF development.[49, 50] Therefore, our study provides new insights into the metabolism‐epigenetic‐fibrosis axis in the context of AF.